[Therapeutic experience with trimethoprim and sulfamethoxazole in infections of infancy and childhood].
D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D005076:Exanthema / Q000139:chemically induced; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D010612:Pharyngitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012852:Sinusitis / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Therapeutische Erfahrung mit Trimethoprim und Sulfamethoxazol bei Infektionen im Säuglings- und Kindesalter.